Answers are grounded in this paper and cite their sources.
Explores handwriting as a biomarker for early Alzheimer’s, suggesting viable detection methods.
Aim: The aim of this paper was to explore stroke-level handwriting dynamics as early behavioral biomarkers for Alzheimer’s disease (AD). Methods: Stroke-level handwriting data were collected from 174 participants (89 probable AD or mild cognitive impairment; 85 cognitive healthy controls). Temporal, kinematic, and pressure features were extracted and aggregated. Classification performance was evaluated using Logistic Regression, Support Vector Machine (SVM), and Random Forest (RF) under five-fold stratified cross-validation. Random forest with SHapley Additive exPlanations (SHAP) was used to interpret feature contributions and temporal trends. Results: Participants with AD exhibited longer and more variable in-air times, slower stroke speed, and higher-pressure variability. SVM achieved the highest ROC-AUC (0.923), while Random Forest demonstrated robust and balanced performance (accuracy = 0.844) and identified key predictive features (mean and variability of in-air time and pressure). Temporal analysis revealed progressive motor hesitation across strokes. Conclusions: Stroke-level handwriting dynamics provide sensitive and interpretable biomarkers for early Alzheimer’s disease detection. Variability in in-air time and related temporal features effectively distinguish Alzheimer’s disease patients from cognitively healthy controls, reflecting underlying motor–cognitive coupling deficits. These findings highlight digital handwriting analysis as a scalable, non-invasive approach for early screening and monitoring, with potential to detect subtle impairments that may precede clinical symptoms.
No takes yet. Share an insight, caveat, or question.
Charity Nyamuchengwa (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: